Among 137 patients with CAD, 44% had a notable endothelial dysfunction characterized by vasoconstriction greater than 20% (71)
Although you will start at 1.5 mg once a day, the starter dosage mentioned above, in practice most patients will have to escalate or titrate their dosage every 30 days until they get to the standard dose of 25 mg daily
In the constantly evolving landscape of medical weight loss, two names frequently emerge at the forefront of the conversation: semaglutide and liraglutide
Just tell us how much weight they lost already! (or maybe thats just me.) Regardless, this is as close as they get: Among in-trial (intention-to-treat principle) patients at week 104: 67.8% lost 5%, 44.2% lost 10%, 22.9% 15%, 11% lost 20%, and 4.9% lost 25% Lets say this another way: 32.2% failed to lose even 5% of body weight, 55.8% failed to lose 10%, 77.1% failed to lose 15% or more, 89% failed to lose 20% or more, and 95.1% failed to lose 25% or more (and remember that weight loss leveled off at about 65 weeks.) They also make claims about the percentage of patients who moved from one BMI category to another (stacking the deck by using the extremely questionable classes of ob*sity to create as many categories as possible.) Given the small amounts of weight loss, this seems to only acknowledge how many people were simply on a BMI cusp to begin with (and also the problematic nature of BMI and other composite measures .) I also have some other questions here
But the real mechanism behind why the body chooses where to burn fat next is more surprising than most people expect
